The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ODM-209, a CYP 11A1 inhibitor in patients with mCRPC: Results from the STESIDES phase 1 study.
 
Alice Bernard-Tessier
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Novartis (Inst); Orion Clinical; Roche
Travel, Accommodations, Expenses - AAA/Endocyte/Novartis; Bayer; Orion Clinical
 
Iben Spanggaard
Honoraria - AstraZeneca
Research Funding - Alligator Bioscience (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cantargia AB (Inst); Genentech (Inst); Genmab (Inst); Incyte (Inst); Loxo/Bayer (Inst); Loxo/Lilly (Inst); MSD (Inst); Novartis (Inst); Orion (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Symphogen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Incyte; Merck/Pfizer
 
Tapio Utriainen
Consulting or Advisory Role - AstraZeneca; Bayer
 
Minna Tanner
Consulting or Advisory Role - AstraZeneca; Daichii-Sankyo; Eli Lilly Finland; Novartis; Roche
Speakers' Bureau - AstraZeneca; Seagen
Research Funding - Lilly (Inst); Novartis (Inst); Orion Finland (Inst); Roche (Inst); Seagen (Inst)
 
Kristoffer Staal Rohrberg
Honoraria - MSD; MSD
Consulting or Advisory Role - Abbvie; Genmab
Research Funding - Alligator Bioscience (Inst); AstraZeneca (Inst); Bayer (Inst); Bioinvent (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Loxo (Inst); Merus (Inst); MonTa Biosciences (Inst); MSD (Inst); Navire (Inst); Novartis (Inst); Orion Clinical (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Repare Therapeutics (Inst); Roche/Genentech (Inst); Symphogen (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst)
 
Natacha Naoun
Speakers' Bureau - Pfizer (Inst)
Expert Testimony - Merck; Merck
Travel, Accommodations, Expenses - Merck; Pfizer
 
Tarja Ikonen
Employment - Orion
 
Pasi Pohjanjousi
Employment - Orion
Stock and Other Ownership Interests - Orion
 
Chris Garratt
Employment - Orion
Stock and Other Ownership Interests - Orion
 
Karim Fizazi
Honoraria - Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst)
Consulting or Advisory Role - Amgen (Inst); Arvinas; Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); CureVac; Daiichi Sankyo Europe GmbH (Inst); Janssen Oncology (Inst); Macrogenics; MSD (Inst); Novartis (Inst); Orion; Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; MSD; Pfizer